Mexico has become a testing ground for psychedelic therapies
From ibogaine to LSD, the benefits of psychedelics are not yet backed up by strong medical evidence
Olivia has suffered with depression and struggled to form romantic attachments ever since she was sexually assaulted. Counselling and medication scarcely helped. So in September 2023 she flew to Mexico and joined a retreat that uses 5-MeO-DMT, a psychedelic compound, as a therapeutic agent. She was “terrified”, but says the drug was “an opening” and that it let her body “feel what it needed to feel to start processing” her assault. She plans to return to Mexico for more psychedelic therapy this year.
Explore more
This article appeared in the The Americas section of the print edition under the headline “A different kind of help”
From the July 6th 2024 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from The Americas
Canada has adopted assisted dying faster than anywhere on Earth
The province of Quebec now allows those with deteriorating illnesses to request an assisted death in advance
Tether’s move to El Salvador is a win for President Nayib Bukele
Why the stablecoin firm has picked the Central American country for its headquarters
From Greenland to Panama and Mexico, leaders are in shock
As Donald Trump eyes fine new pieces of real estate in the Americas and beyond
Canada and America have been fighting about timber for 40 years
As Donald Trump takes office, the chances of a lumber deal look slim
Justin Trudeau steps down, leaving a wrecked party and a divided Canada
Mark Carney and Chrystia Freeland are among those tipped as the next Liberal leader
Does made in Mexico mean made by China?
Donald Trump believes Mexico is a trojan horse for Chinese mercantilism